68 studies found for:    "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency" OR "Congenital Adrenal Hyperplasia" OR "Adrenal Hyperplasia, Congenital"
Show Display Options
Rank Status Study
21 Completed A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency
Condition: 21-hydroxylase Deficiency
Intervention: Drug: Abiraterone acetate
22 Completed Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH
Conditions: Endocrine Disease;   Adrenal Insufficiency;   Congenital Adrenal Hyperplasia
Intervention: Drug: Hydrocortisone Modified Release Capsules
23 Completed Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: Nifedipine
24 Enrolling by invitation Natural History Study of Patients With Excess Androgen
Conditions: Congenital Adrenal Hyperplasia (CAH);   Familial Male-Limited Precocious Puberty (FMPP)
25 Unknown  Tweens to Teens Project at Penn State
Condition: Congenital Adrenal Hyperplasia
Intervention: Behavioral: Questionnaires/Interviews
26 Recruiting Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Children
Conditions: Autoimmune Disease;   Congenital Adrenal Hyperplasia;   Healthy;   Mental Disorder Diagnosed in Childhood;   Neurologic Manifestations
27 Recruiting Decision Support for Parents Receiving Information About Child's Rare Disease
Conditions: Disorder of Sex Development;   Intersex Conditions;   Congenital Adrenal Hyperplasia;   Hypospadias
Intervention: Behavioral: Decision Support Tool
28 Completed Clinical Evaluation of NeoPlex4 Assay and NeoPlex System
Conditions: Adrenal Hyperplasia, Congenital;   Congenital Hypothyroidism;   Cystic Fibrosis
29 Withdrawn Gene Polymorphisms Influencing Steroid Synthesis and Action
Conditions: Disorders of Sex Development;   Congenital Adrenal Hyperplasia;   Congenital Adrenal Hypoplasia;   Adrenal Insufficiency;   Mineralocorticoid Deficiency;   Intersex
30 Unknown  Mutation Analysis of 17α-Hydroxylase
Conditions: Pseudohermaphroditism;   Congenital Adrenal Hyperplasia;   Hypertension
Intervention: Procedure: blood drawing
31 Recruiting Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia
Conditions: Polycystic Ovary Syndrome;   Hyperandrogenism;   Puberty
Intervention: Other: Phenotype/genotype assessment
32 Enrolling by invitation Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant
Conditions: Polycystic Ovary Syndrome;   Hyperandrogenism
Interventions: Drug: metformine;   Drug: placebo;   Drug: clomiphene citrate
33 Recruiting Phlebotomy and Polycystic Ovary Syndrome
Conditions: Hyperandrogenism;   Metabolic Cardiovascular Syndrome
Interventions: Procedure: Phlebotomy;   Drug: ethinylestradiol;   Drug: Cyproterone Acetate
34 Not yet recruiting Ultrasound Three-dimensional Characterization of Ovarian Morphology in Women With Polycystic Ovary Syndrome (PCOS)
Conditions: PCOS;   Hyperandrogenism
Interventions: Procedure: Ultrasound;   Procedure: Determination of concentrations of androgens;   Device: Three dimensional ultrasound probe
35 Recruiting Assessment of Day-night Secretion of Progesterone and LH Across Puberty
Conditions: Puberty;   Hyperandrogenism
Intervention: Other: Blood sampling
36 Recruiting Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants
Conditions: Polycystic Ovarian Syndrome;   Hyperandrogenism;   Menstrual Irregularities
Interventions: Drug: 20 mcg ethinylestradiol /3 mg drospirenone;   Drug: 20 mcg ethinylestradiol/3 mg drospirenone and Selmevit;   Drug: 30 mcg ethinylestradiol/3 mg drospirenone;   Drug: 30 mcg ethinylestradiol/3 mg drospirenone and Selmevit;   Drug: 35 mcg ethinylestradiol/2 mg cyproterone;   Drug: 35 mcg ethinylestradiol/2 mg cyproterone and Selmevit
37 Completed Presentations of Hyperandrogenic Phenotypes in Taiwanese Women
Conditions: Hyperandrogenism,;   Polycystic Ovary Syndrome,;   Metabolic Syndrome,;   Insulin Resistance,;   Cardiovascular Disease.
38 Recruiting Androgen Excess as a Mechanism for Adipogenic Dysfunction in PCOS Women
Condition: Polycystic Ovary Syndrome (PCOS)
Intervention: Drug: Flutamide
39 Completed Effect of a Commonly Used Antibiotic, Doxycycline, in Women With Polycystic Ovarian Syndrome
Conditions: Polycystic Ovarian Syndrome (PCOS);   Irregular Menstrual Cycles;   Androgen Excess
Interventions: Drug: doxycycline;   Other: Sugar Pill
40 Completed Effects of Androgen Administration on Inflammation in Normal Women
Condition: Hyperandrogenism
Interventions: Dietary Supplement: Dehydroepiandrosterone (DHEA);   Other: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years